말기 심부전의 비약물적 치료

키워드

참고문헌 (69)

1. Fonarow GC, "Associations between outpatient heart failure process-of-care measures and mortality", Circulation, 123, pp.1601~1610 (2011)
2. "Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS): the CONSENSUS Trial Study Group", N Engl J Med, 316, pp.1429~1435 (1987)
3. "Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure: the SOLVD Investigators", N Engl J Med, 325, pp.293~302 (1991)
4. "Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions: the SOLVD Investigattors", N Engl J Med, 327, pp.685~691 (1992)
5. "Effect of metoprolol CR", XL in chronic heart failure: metoprolol CR, Lancet, pp.1999, 353[DOI]
6. "The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial", Lancet, 353, pp.9~13 (1999)
7. Bardy GH, "Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure", N Engl J Med, 352, pp.225~237 (2005)
8. Cleland JG, "The effect of cardiac resynchronization on morbidity and mortality in heart failure", N Engl J Med, 352, pp.1539~1549 (2005)
9. Packer M, "Effect of carvedilol on survival in severe chronic heart failure", N Engl J Med, 344, pp.1651~1658 (2001)
10. Pitt B, "The effect of spironolactone on morbidity and mortality in patients with severe heart failure: randomized aldactone avaluation study investigators", N Engl J Med, 341, pp.709~717 (1999)
11. Cuffe MS, "Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial", JAMA, 287, pp.1541~1547 (2002)
12. Follath F, "Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial", Lancet, 360, pp.196~202 (2002)
13. O'Connor CM, "Effect of nesiritide in patients with acute decompensated heart failure", N Engl J Med, 365, pp.32~43 (2011)
14. McMurray JJ, "Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials", JAMA, 298, pp.2009~2019 (2007)
15. Hunt SA, "2009 focused update incorporated into the ACC", AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation, J Am Coll Cardiol, pp.2009, 53[DOI]
16. Stewart GC, "Mechanical circulatory support for advanced heart failure: patients and technology in evolution", Circulation, 125, pp.1304~1315 (2012)
17. Kar B, "Percutaneous circulatory support in cardiogenic shock: interventional bridge to recovery", Circulation, 125, pp.1809~1817 (2012)
18. Kantrowitz A, "Initial clinical experience with intraaortic balloon pumping in cardiogenic shock", JAMA, 203, pp.113~118 (1968)
19. Sanborn TA, "Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry: should we emergently revascularize occluded coronaries for cardiogenic shock?", J Am Coll Cardiol, 36(3 Suppl A), pp.1123~1129 (2000)
20. Barron HV, "The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2", Am Heart J, 141, pp.933~939 (2001)
21. Trost JC, "Intra-aortic balloon counterpulsation", Am J Cardiol, 97, pp.1391~1398 (2006)
22. Gold HK, "Intraaortic balloon pumping for ventricular septal defect or mitral regurgitation complicating acute myocardial infarction", Circulation, 47, pp.1191~1196 (1973)
23. Loisance DY, "Ventricular septal defect after acute myocardial infarction: early repair", J Thorac Cardiovasc Surg, 80, pp.61~67 (1980)
24. Gunstensen J, "Evolving indications for preoperative intraaortic balloon pump assistance", Ann Thorac Surg, 22, pp.535~545 (1976)
25. Christenson JT, "Evaluation of preoperative intra-aortic balloon pump support in high risk coronary patients", Eur J Cardiothorac Surg, 11, pp.1097~1103 (1997)
26. Champsaur G, "Use of the Abiomed BVS System 5000 as a bridge to cardiac transplantation", J Thorac Cardiovasc Surg, 100, pp.122~128 (1990)
27. Dekkers RJ, "Five-year clinical experience with Abiomed BVS 5000 as a ventricular assist device for cardiac failure", Perfusion, 16, pp.13~18 (2001)
28. De Robertis F, "Clinical performance with the Levitronix Centrimag short-term ventricular assist device", J Heart Lung Transplant, 25, pp.181~186 (2006)
29. Doll N, "Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock", Ann Thorac Surg, 77, pp.151~157 (2004)
30. Sheu JJ, "Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock", Crit Care Med, 38, pp.1810~1817 (2010)
31. 윤수현, "Thioredoxin, adiponectin and clinical course of acute fulminant myocarditis", HEART, 97(13), pp.1067~1073, B M J PUBLISHING GROUP
32. Maejima Y, "Long-term prognosis of fulminant myocarditis rescued by percutaneous cardiopulmonary support device", Circ J, 68, pp.829~833 (2004)
33. Gariboldi V, "Mobile extracorporeal membrane oxygenation unit expands cardiac assist surgical programs", Ann Thorac Surg, 90, pp.1548~1552 (2010)
34. Arlt M, "Hand-held minimised extracorporeal membrane oxygenation: a new bridge to recovery in patients with out-of-centre cardiogenic shock", Eur J Cardiothorac Surg, 40, pp.689~694 (2011)
35. Jung C, "Providing macro- and microcirculatory support with the Lifebridge System during high-risk PCI in cardiogenic shock", Heart Lung Circ, 18, pp.296~298 (2009)
36. Cofer BR, "Extracorporeal membrane oxygenation in the management of cardiac failure secondary to myocarditis", J Pediatr Surg, 28, pp.669~672 (1993)
37. Ko WJ, "Prolonged extracorporeal membrane oxygenation support for acute respiratory distress syndrome", J Formos Med Assoc, 105, pp.422~426 (2006)
38. Burkhoff D, "A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock", Am Heart J, 152, pp.469~ (2006)
39. Thiele H, "Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock", Eur Heart J, 26, pp.1276~1283 (2005)
40. Bruckner BA, "Clinical experience with the TandemHeart percutaneous ventricular assist device as a bridge to cardiac transplantation", Tex Heart Inst J, 35, pp.447~450 (2008)
41. Gregoric ID, "The TandemHeart as a bridge to a long-term axial-flow left ventricular assist device (bridge to bridge)", Tex Heart Inst J, 35, pp.125~129 (2008)
42. Brinkman WT, "Role of a percutaneous ventricular assist device in decision making for a cardiac transplant program", Ann Thorac Surg, 88, pp.1462~1466 (2009)
43. Chandra D, "Usefulness of percutaneous left ventricular assist device as a bridge to recovery from myocarditis", Am J Cardiol, 99, pp.1755~1756 (2007)
44. Seyfarth M, "A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction", J Am Coll Cardiol, 52, pp.1584~1588 (2008)
45. Rajagopal V, "A novel percutaneous mechanical biventricular bridge to recovery in severe cardiac allograft rejection", J Heart Lung Transplant, 29, pp.93~95 (2010)
46. Wiktor DM, "Successful combined use of Impella Recover 2.5 device and intra-aortic balloon pump support in cardiogenic shock from acute myocardial infarction", ASAIO J, 56, pp.519~521 (2010)
47. Portner PM, "Implantable electrical left ventricular assist system: bridge to transplantation and the future", Ann Thorac Surg, 47, pp.142~150 (1989)
48. Rose EA, "Long-term use of a left ventricular assist device for end-stage heart failure", N Engl J Med, 345, pp.1435~1443 (2001)
49. Slaughter MS, "Advanced heart failure treated with continuous-flow left ventricular assist device", N Engl J Med, 361, pp.2241~2251 (2009)
50. Miller LW, "Use of a continuousflow device in patients awaiting heart transplantation", N Engl J Med, 357, pp.885~896 (2007)
51. Stewart GC, "Keeping left ventricular assist device acceleration on track", Circulation, 123, pp.1559~1568 (2011)
52. Stehlik J, "2011-2020: decade of the ventricular assist device", Curr Opin Cardiol, 26, pp.230~231 (2011)
53. Kirklin JK, "Third INTERMACS annual report: the evolution of destination therapy in the United States", J Heart Lung Transplant, 30, pp.115~123 (2011)
54. Pagani FD, "Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device", J Am Coll Cardiol, 54, pp.312~321 (2009)
55. Starling RC, "Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support)", J Am Coll Cardiol, 57, pp.1890~1898 (2011)
56. Fang JC, "Rise of the machines: left ventricular assist devices as permanent therapy for advanced heart failure", N Engl J Med, 361, pp.2282~2285 (2009)
57. Cowger J, "The development of aortic insufficiency in left ventricular assist device-supported patients", Circ Heart Fail, 3, pp.668~674 (2010)
58. Wilson SR, "Evaluation for a ventricular assist device: selecting the appropriate candidate", Circulation, 119, pp.2225~2232 (2009)
59. Stehlik J, "The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report: 2010", J Heart Lung Transplant, 29, pp.1089~1103 (2010)
60. John R, "Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables", J Thorac Cardiovasc Surg, 140, pp.174~181 (2010)
61. Zierer A, "Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support", Ann Thorac Surg, 84, pp.515~520 (2007)
62. Holman WL, "Device related infections: are we making progress?", J Card Surg, 25, pp.478~483 (2010)
63. Letsou GV, "Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device", J Heart Lung Transplant, 24, pp.105~109 (2005)
64. Crow S, "Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices", J Thorac Cardiovasc Surg, 137, pp.208~215 (2009)
65. Uriel N, "Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation", J Am Coll Cardiol, 56, pp.1207~1213 (2010)
66. Meyer AL, "Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device", Circ Heart Fail, 3, pp.675~681 (2010)
67. Mancini D, "Selection of cardiac transplantation candidates in 2010", Circulation, 122, pp.173~183 (2010)
68. Wilson SR, "Ventricular assist devices the challenges of outpatient management", J Am Coll Cardiol, 54, pp.1647~1659 (2009)
69. Baldwin JT, "NHLBI's program for VAD therapy for moderately advanced heart failure: the REVIVE-IT pilot trial", J Card Fail, 16, pp.855~858 (2010)

관련 논문AI추천